A Study to Evaluate EDG-7500 in People With Renal Impairment

Clinical trial NCT07034768 · COMPLETED

Trial details

NCT number: NCT07034768
Sponsor: Edgewise Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairments

Start date: 2025-07-22
Primary completion: 2025-12-22
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.